Zauatbayeva G, Syzdykova L, Keyer V, Shustov A, Abilmagzhanov A, Zhurynov M. NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS. Eurasian Journal of Applied Biotechnology [Internet]. 2022Jul.9 [cited 2024Apr.26];(2):44-53. Available from: https://biotechlink.org/index.php/journal/article/view/338